Global Musculoskeletal Disorders Drugs Market Report 2020 - Opportunities And Strategies, Market Forecast And Trends
14 Dec, 2020
Avail up to 50% off on ALL research reports at: https://www.thebusinessresearchcompany.com/global-market-reports. Offer applies until Dec 31st!
The global musculoskeletal disorders drugs market is expected to decline from $85.7 billion in 2019 to $75.5 billion in 2020 at a compound annual growth rate (CAGR) of -12%. The decline is mainly due to the COVID-19 outbreak and the measures to contain it. COVID-19 pandemic is affecting industries across the globe including the pharmaceutical sector. The restrictions on non-essential medical services coupled with slowed production of drugs due to extended factory closures in various countries, shortage of APIs and other chemicals, and rise in prices of key ingredients are the key factors for this decline. The market is then expected to recover and grow at a CAGR of 4% from 2021 and reach $94.8 billion in 2023.
The musculoskeletal disorders drugs market consists of sales of musculoskeletal disorders drugs and related services by entities (organizations, sole traders and partnerships) that produce musculoskeletal disorders drugs to treat musculoskeletal disorders such as arthritis, osteoporosis, osteomalacia, and other disorders. This industry includes establishments that produce drugs to treat rheumatoid arthritis, muscle relaxants to reduce muscle pain, and other drugs used in treating osteoarthritis, analgesics drugs, immunosuppressives.
Request For A Sample For The Global Musculoskeletal Disorders Drugs Market Report:
The global musculoskeletal disorders drugs market is further segmented based type, distribution channel, route of administration, drug classification, mode of purchase and geography.
By Type: Drugs For Rheumatoid Arthritis, Muscle Relaxants, Others - Musculoskeletal Disorders Drugs.
By Distribution Channel: Hospital Pharmacies, Retail Pharmacies/ Drug Stores, Others.
By Route Of Administration: Oral, Parenteral, Others.
By Drug Classification: Branded Drugs, Generic Drugs.
By Mode Of Purchase: Prescription-Based Drugs, Over-The-Counter Drugs.
By Geography: The global musculoskeletal disorders drugs market is segmented into North America, South America, Asia-Pacific, Eastern Europe, Western Europe, Middle East and Africa. Among these regions, the North American musculoskeletal disorders drugs market accounts for the largest share of 53% in the global musculoskeletal disorder drugs market.
Read More On The Report For The Global Musculoskeletal Disorders Drugs Market At:
Trends In The Musculoskeletal Disorders Drugs Market
Introduction of advanced pain free drug delivery technologies is promoting the use of musculoskeletal drugs. Drug delivery systems refer to methods or processes used to administer a pharmaceutical compound to achieve a therapeutic effect in humans or animals. Drug delivery products such as intrathecal pumps are being used to deliver muscle relaxants such as baclofen directly into spinal cord to provide instant relief. Intra-articular drug delivery systems are also widely being used to administer medicines to treat arthritis. In addition, these products reduce spasticity symptoms and lower the side effects caused by oral spasticity medications.
Musculoskeletal Disorders Drugs Global Market Report 2020 is one of a series of new reports from The Business Research Company that provides musculoskeletal disorders drugs market overviews, analyzes and forecasts market size and growth for the global musculoskeletal disorders drugs market, musculoskeletal disorders drugs market share, musculoskeletal disorders drugs market players, musculoskeletal disorders drugs market segments and geographies, musculoskeletal disorders drugs market’s leading competitors’ revenues, profiles and market shares. The musculoskeletal disorders drugs market report identifies top countries and segments for opportunities and strategies based on market trends and leading competitors’ approaches.